Meeting
2019 ASCO Annual Meeting
Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results.
Authors
Mario E. Lacouture
Memorial Sloan Kettering Cancer Center, New York, NY
Mario E. Lacouture , Rangaprasad Sarangarajan , Joaquin Juan Jimenez , Michael A. Kiebish , Niven R. Narain , Brian Berman , Shari Beth Goldfarb
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Clinical Trial Registration Number
NCT01588522
Citation
J Clin Oncol 37, 2019 (suppl; abstr 11608)
DOI
10.1200/JCO.2019.37.15_suppl.11608
Abstract #
11608
Poster Bd #
300
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Enfortumab vedotin treatment regimens and efficacy in urothelial carcinoma: The Mayo Clinic experience.
First Author: Tara Ballouz
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Safety and efficacy of chemotherapy for patients with unresectable pancreatic cancer concomitant with collagen disease: A multicenter retrospective observational study.
First Author: Hiroyuki Asama
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical pharmacology profile of the claudin 18.2 antibody zolbetuximab.
First Author: Jianning Yang
Poster
2023 ASCO Annual Meeting
Efficacy of paxman scalp cooling system at lower temperatures for prevention of anthracycline associated chemotherapy induced alopecia.
First Author: Shari Beth Goldfarb